Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 1321 Patients With Nonvalvular Atrial Fibrillation
- 8 October 2002
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (15), 1962-1967
- https://doi.org/10.1161/01.cir.0000033220.97592.9a
Abstract
Background— Epidemiological studies have identified clinical and echocardiographic factors associated with increased stroke risk in atrial fibrillation (AF), but mechanisms linking these factors to stroke in AF are incompletely understood. We hypothesized that stroke risk factors may be associated with increased endothelial damage/dysfunction and platelet activation among patients with AF. Methods and Results— We measured plasma levels of von Willebrand factor (vWF, a marker of endothelial damage/dysfunction) and soluble P-selectin (sP-sel, a marker of platelet activation) by ELISA in 1321 participants in the Stroke Prevention in Atrial Fibrillation (SPAF) III study and related these indices to the presence of stroke risk factors and cardiovascular disease. Age (P<0.001), prior cerebral ischemia (P<0.01), recent heart failure (P<0.001), diabetes (P<0.001), and body mass index (P<0.001) were independently associated with increased vWF (r2 adjusted=9%). Independent associates of increased sP-sel were diabet...Keywords
This publication has 25 references indexed in Scilit:
- Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendageJournal of the American College of Cardiology, 2001
- Hemostatic state and atrial fibrillation (The Framingham Offspring Study)The American Journal of Cardiology, 2001
- Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available.The American Journal of Cardiology, 1998
- Transesophageal Echocardiographic Correlates of Clinical Risk of Thromboembolism in Nonvalvular Atrial FibrillationJournal of the American College of Cardiology, 1998
- Patients With Nonvalvular Atrial Fibrillation at Low Risk of Stroke During Treatment With Aspirin: Stroke Prevention in Atrial Fibrillation III StudyJAMA, 1998
- Atrial Fibrillation Activates Platelets and Coagulation in a Time-Dependent Manner: A Study in Patients With Paroxysmal Atrial FibrillationJournal of the American College of Cardiology, 1997
- Effects of desmopressin on circulating P‐selectinBritish Journal of Haematology, 1996
- The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion moleculesBritish Journal of Haematology, 1996
- Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.Heart, 1995
- Increased intracardiovascular clotting in patients with chronic atrial fibrillationJournal of the American College of Cardiology, 1990